The U.S. Drug Enforcement Administration (DEA) has issued a critical public safety alert regarding the increasing presence of two potent and lethal synthetic substances nitazenes and bromazolam in the nation’s illicit drug supply.

Officials warn that both drugs significantly escalate the risk of accidental overdose.

Nitazenes, a class of synthetic opioids, are the most immediate concern due to their extreme potency.

According to DEA lab findings, some nitazene can match or surpass the strength of fentanyl by as much as 20 to 40 percent.

Originally developed in the 1950s but never approved for human medical use due to toxicity.

Nitazenes are now being sourced globally and smuggled into the U.S.

Compounding the crisis is the rise of bromazolam, an unregulated synthetic benzodiazepine that has become the most common “designer Xanax” found in seizures across the country.

The danger of bromazolam lies in its sedative effects, which can cause respiratory depression, especially when combined with opioids.

While naloxone (Narcan) is effective at reversing opioid overdoses, it is ineffective against a benzodiazepine overdose.

This combination creates a deadly combination that complicates emergency response efforts.

Law enforcement agencies and public health officials are urging extreme caution.

The DEA stresses that any drug not obtained from a licensed pharmacy, under a doctor’s prescription should be considered potentially lethal.

The emergence of nitazenes and bromazolam underscores the continuing volatility of the illicit drug market.

Traffickers constantly introduce new compounds to evade regulatory control, placing the public at increasing and often unrecognized risk.

For more news from across the Shenandoah Valley, click here.